An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants

Completed

Phase 1 Results N/A

Summary of Purpose

The purpose of this study is to investigate the effect of taking multiple doses of BMS-986177 when aspirin is taken once-daily. Eligible participants will receive twice-daily doses of BMS-986177 or placebo, with a once-daily dose of aspirin. The safety, tolerability and movement of BMS-986177 into, through and out of the body (pharmacokinetics/PK) will be assessed, as will the effect of BMS-986177 on the PK of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 January 2018.

18 Oct 2017 30 Oct 2017 16 Nov 2017 16 Nov 2017 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts

  • First line of the email MUST contain NCT# and Site #

  • Recruiting sites have contact information. Please contact sites directly. If there is no contact information, please

    Clinical.Trials@bms.com email